Endeavor selects PD Neurotechnology among 9 new companies in the Scale-up program

Athens, 11.01.2021: PD Neurotechnology® was chosen by Endeavor, among 9 companies for the 2nd cycle of the Endeavor Scale-Up program. The program selects start-ups that have the potential for global growth, job creation and attracting wealth to the local economy.

The Endeavor Scale-Up program is an initiative of Endeavor Greece, the Greek part of an international non-profit organization that selects and supports fast-growing businesses around the world, with the help of the world's leading business leaders and investors. Since 1997, more than 2089 Endeavor Entrepreneurs have been selected from 1200 companies worldwide, which have secured more than 4.1 million jobs, while in 2019 they recorded turnovers of over 24 billion euros.

During their participation in the program, entrepreneurs will gain access to strategic guidance from specialized mentors, funding through Endeavor's international investor network, but also talent, benefiting from the organization's cooperation with universities and companies internationally. The selected companies will also have the opportunity to participate in international organizations, thus gaining access to the network and the members of the organization worldwide.

Panagiotis Karabinis, General Manager of Endeavor Greece, said “The main goal of the program is to early select the most promising technology companies founded by Greeks and to contribute to their international development and eventually lead to their integration into the global network of Endeavor, as Endeavor Entrepreneurs".

On his end, Nikos Moschos, Business Director of PDNeurotechnology®, said: “Our selection by Endeavor, a pioneering organization that has globaly supported new entrepreneurship for 33 years, is an additional validation of the business plan and innovation of PD Neurotechnology®. Endeavor’s network already includes important companies, the development example of which we want to follow".


About PDNeurotechnology®

PD Neurotechnology Ltd is an award-winning high tech medical device company, founded in London, UK in 2015, by a team of experts in patient monitoring systems for movement disorders.

Sales and marketing is based in Athens, Greece, and R&D, Production, Distribution, Clinical Studies and Support in Ioannina, Greece, where the company has a fully equipped electronic laboratory with the ability to produce and test prototypes. The company focuses its activities on the research, development, production, distribution, sales and marketing of systems and services, which include medical devices, sensors and software for the monitoring, diagnosis and treatment of patients suffering from Parkinson’s disease and other movement disorders.